Is GPT-4o HIPAA-eligible in Azure OpenAI Service for production use?

Question

Is GPT-4o HIPAA-eligible in Azure OpenAI Service for production use?

Yamara Pinon 0

Hello,

I need official confirmation regarding HIPAA compliance planning to deploy Azure OpenAI.

Questions:

Is GPT-4o covered under Microsoft's Business Associate Agreement (BAA) for HIPAA in Azure OpenAI Service?
Can we deploy GPT-4o for text-based inputs in East US or East US 2 to process protected health information (PHI) in production?
Is there official documentation confirming GPT-4o as HIPAA-eligible?

This is critical for our production architecture.

Thank you.

0 comments

2 answers

Your answer

Answer 1

Welcome to Microsoft Q&A

Hello @Yamara Pinon I hope you are doing well,

Azure OpenAI Service is listed as a HIPAA‑eligible service in the Microsoft Trust Center. That means when your tenant has a signed Business Associate Agreement (BAA) with Microsoft, workloads using Azure OpenAI — including GPT‑4o — are covered under HIPAA. Eligibility is defined at the service level, not per model. If GPT‑4o is available in Azure OpenAI, it inherits the service’s HIPAA compliance status.

Regional Deployment East US and East US 2 are HIPAA‑eligible regions for Azure OpenAI workloads. Deploying GPT‑4o in those regions for text‑based PHI processing is supported, provided your organization’s BAA is active. You can confirm GPT‑4o availability in those regions via the Azure OpenAI model availability documentation.

Documentation Confirmation There is no separate HIPAA eligibility matrix per model. Instead, HIPAA eligibility is tied to the Azure OpenAI Service itself. GPT‑4o is listed in the model availability tables, and the service is HIPAA‑eligible under the BAA. This is the official confirmation you can cite in your architecture documentation.

Short answer: There is no separate Microsoft document that names GPT‑4o explicitly as “HIPAA‑eligible”; instead Microsoft treats HIPAA eligibility at the service level — Azure OpenAI Service

Architectural Recommendation

Ensure your tenant has a signed BAA with Microsoft.

Deploy GPT‑4o in East US or East US 2 where HIPAA support is documented.

Validate with your compliance officer and Microsoft account team before production rollout.

😊 If my answer helped you resolve your compliance planning, please consider marking it as the correct answer. This helps others in the community find solutions more easily. Thanks!

Jose Benjamin Solis Nolasco 12,201 Reputation points Volunteer Moderator

2026-06-17T23:36:40.45+00:00

@Yamara Pinon Just following up do you need more guidance or assistance?
Jose Benjamin Solis Nolasco 12,201 Reputation points Volunteer Moderator

2026-06-22T18:30:35.7633333+00:00

@Yamara Pinon Just following up do you need more guidance or assistance?

Answer 2

HIPAA eligibility for Azure OpenAI (including GPT‑4o) is determined at the service/feature and region level, not per individual model name in isolation. A workload is HIPAA-eligible only when:
- It runs in an Azure region where the required Azure AI/OpenAI features are listed as supported for HIPAA-covered workloads, and
- It is covered under a signed Microsoft Business Associate Agreement (BAA) for the tenant.
The provided context shows HIPAA regional support tables for Azure Databricks AI/ML features, but does not include a HIPAA eligibility matrix for Azure OpenAI models such as GPT‑4o. Therefore, from the given information, GPT‑4o cannot be explicitly confirmed or denied as HIPAA-eligible under the BAA.
The context does not state that GPT‑4o in Azure OpenAI Service, in East US or East US 2, is approved for processing PHI in production. It only shows that various AI/ML features (for example, Model Serving, AI Gateway, AI Guardrail, Vector Search, etc.) have HIPAA regional support across many regions, including East US and East US 2, but it does not map those entries specifically to Azure OpenAI GPT‑4o usage. As a result, based on the context alone, there is no definitive confirmation that GPT‑4o in East US/East US 2 can be used today for PHI processing in production.
The context does not contain any official documentation statement that explicitly names GPT‑4o as HIPAA-eligible. It only provides:
- A model availability table for Azure OpenAI models (including GPT‑4o) by region.
- Separate HIPAA “Regional support for features” tables for Azure Databricks capabilities.
None of these explicitly assert that GPT‑4o is HIPAA-eligible or covered under the BAA.

For authoritative confirmation on:

Whether Azure OpenAI (and specifically GPT‑4o) is in-scope for HIPAA under the Microsoft BAA, and
Whether East US / East US 2 deployments of GPT‑4o are approved for PHI,

the correct path is to:

Review the official Azure OpenAI and HIPAA/BAA documentation in the Microsoft Trust Center and Azure compliance documentation, and
If still unclear, open a formal Microsoft support request or work with the organization’s Microsoft account team to obtain written confirmation for compliance and production use with PHI.

References: